Response to Tanezumab, as Assessed by Outcome Measures in Rheumatology-Osteoarthritis Research Society International Criteria, in Patients With Osteoarthritis of the Knee or Hip
Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2018.02.601
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Elsevier BV